Clinical study of rezvilutamide inhibiting the flare effect of GnRH agonists in the treatment of newly diagnosed metastatic prostate cancer.

被引:0
|
作者
Wang, Shaogang
Wang, Zhihua
Hu, Zhiquan
Yang, Chunguang
机构
[1] Huazhong Univ Sci & Technol, Wuhan, Peoples R China
[2] Huazhong Univ, Tongji Hosp, Tongji Med Coll, Urol Dept, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Urol, Wuhan, Peoples R China
[4] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
关键词
3282-3221-3717; 261-566-9690; 3282-3221-2748-2527; 613-225-2575-2447; 283-2494-5577-5578; 261-436; 613-135-4642-282-153; 6; 5; 4; 2; 1917; 138; 73; 238; 3; 1; 38092-25779;
D O I
10.1200/JCO.2024.42.4_suppl.TPS233
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:TPS233 / TPS233
页数:1
相关论文
共 50 条
  • [31] Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base Sweden
    George, Gincy
    Garmo, Hans
    Rudman, Sarah
    Holmberg, Lars
    Robinson, David
    Stattin, Par
    Adolfsson, Jan
    Van Hemelrijck, Mieke
    SCANDINAVIAN JOURNAL OF UROLOGY, 2020, 54 (01) : 20 - 26
  • [32] Treatment of patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) in Belgium: a real world data analysis
    Lambert, E.
    Hollebosch, S.
    van Praet, C.
    Van Bruwaene, S.
    Duck, L.
    De Roock, W.
    van Wambeke, S.
    Ghysel, C.
    Ameye, F.
    Schatteman, P.
    Vandenbroucke, F.
    Sautois, B.
    Baekelandt, F.
    Ost, D.
    Fransis, K.
    Filleul, B.
    Remondo, C.
    Wynendaele, W.
    Bamelis, B.
    Logghe, P.
    Vergauwe, E.
    Denies, E.
    Joniau, S.
    Lumen, N.
    ACTA CLINICA BELGICA, 2022, 77 (06) : 897 - 905
  • [33] TREATMENT OF NEWLY DIAGNOSED METASTATIC PROSTATE-CANCER PATIENTS WITH CHEMOTHERAPY AGENTS IN COMBINATION WITH HORMONES VERSUS HORMONES ALONE
    MURPHY, GP
    BECKLEY, S
    BRADY, MF
    CHU, TM
    DEKERNION, JB
    DHABUWALA, C
    GAETA, JF
    GIBBONS, RP
    LOENING, SA
    MCKIEL, CF
    MCLEOD, DG
    PONTES, JE
    PROUT, GR
    SCARDINO, PT
    SCHLEGEL, JU
    SCHMIDT, JD
    SCOTT, WW
    SLACK, NH
    SOLOWAY, MS
    CANCER, 1983, 51 (07) : 1264 - 1272
  • [34] Docetaxel versus abiraterone in newly diagnosed metastatic prostate cancer: Study from tertiary care cancer centre in a developing country
    Hussain, S. M.
    Gautam, G.
    Ahluwalia, P.
    Punnakal, A.
    Chaturvedi, H.
    Gupta, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [36] Five year follow up of a phase II study of cytotoxic immunotherapy combined with radiation in newly diagnosed prostate cancer.
    Aguilar, L. K.
    Teh, B.
    Mai, W.
    Caillouet, J.
    Ayala, G.
    Aguilar-Cordova, E.
    Butler, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 250S - 250S
  • [37] Far from the truth: Real-world treatment patterns amongst newly diagnosed metastatic prostate cancer in the era of treatment intensification
    Yang, Xinyan
    Tan, Yu Guang
    Chen, Weiren
    Gatsinga, Rene
    Chen, Kenneth
    Tay, Kae Jack
    Yuen, John Shyi Peng
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 : 28 - 28
  • [38] Far from the truth: Real-world treatment patterns among newly diagnosed metastatic prostate cancer in the era of treatment intensification
    Yang, Xinyan
    Tan, Yu Guang
    Gatsinga, Rene
    Chen, Weiren
    Huang, Hong Hong
    Loong, Jeffrey Tuan Kit
    Chua, Melvin Lee Kiang
    Rajasekaran, Tanujaa
    Kanesvaran, Ravindran
    Tay, Kae Jack
    Chen, Kenneth
    Yuen, John Shyi Peng
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (11) : 991 - 999
  • [39] FAR FROM THE TRUTH: REAL-WORLD TREATMENT PATTERNS AMONG NEWLY DIAGNOSED METASTATIC PROSTATE CANCER IN THE ERA OF TREATMENT INTENSIFICATION
    Yang, XinYan
    Tan, Yu Guang
    Gatsinga, Rene
    Chen, Weiren
    Huang, Hong Hong
    Tuan, Jeffrey
    Chua, Melvin
    Rajasekaran, Tanujaa
    Kanesvaran, Ravindran
    Tay, Kae Jack
    Chen, Kenneth
    Yuen, John
    JOURNAL OF UROLOGY, 2023, 209 : E492 - E493
  • [40] Metastatic castration-resistant prostate cancer. Clinical data, new treatment options and therapy monitoring
    Miller, K.
    Albers, P.
    Eichenauer, R.
    Geiges, G.
    Grimm, M-O.
    Koenig, F.
    Mickisch, G.
    Pfister, D.
    Schwentner, C.
    Suttmann, H.
    Zastrow, S.
    UROLOGE, 2016, 55 (09): : 1206 - 1212